Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.
Kim M, Shim HS, Kim S, Lee IH, Kim J, Yoon S, Kim HD, Park I, Jeong JH, Yoo C, Cheon J, Kim IH, Lee J, Hong SH, Park S, Jung HA, Kim JW, Kim HJ, Cha Y, Lim SM, Kim HS, Lee CK, Kim JH, Chun SH, Yun J, Park SY, Lee HS, Cho YM, Nam SJ, Na K, Yoon SO, Lee A, Jang KT, Yun H, Lee S, Kim JH, Kim WS. Kim M, et al. Among authors: lee ck, lee hs, lee j, lee ih, lee a, lee s. Cancer Res Treat. 2023 Nov 29. doi: 10.4143/crt.2023.1043. Online ahead of print. Cancer Res Treat. 2023. PMID: 38037319 Free article.
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Ahn BC, Lee JH, Kim MH, Pyo KH, Lee CK, Lim SM, Kim HR, Cho BC, Hong MH. Ahn BC, et al. Among authors: lee ck, lee jh. Cancers (Basel). 2021 Jun 21;13(12):3096. doi: 10.3390/cancers13123096. Cancers (Basel). 2021. PMID: 34205733 Free PMC article.
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.
Cheon J, Lee CK, Sang YB, Choi HJ, Kim MH, Ji JH, Ko KH, Kwon CI, Kim DJ, Choi SH, Kim C, Kang B, Chon HJ. Cheon J, et al. Among authors: lee ck. Ther Adv Med Oncol. 2021 Aug 7;13:17588359211035983. doi: 10.1177/17588359211035983. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34394748 Free PMC article.
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.
Bang YH, Lee CK, Yoo C, Chon HJ, Hong M, Kang B, Kim HD, Park SR, Choi WM, Choi J, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Ryu MH, Ryoo BY. Bang YH, et al. Among authors: lee d, lee ck, lee hc. Ther Adv Med Oncol. 2022 May 14;14:17588359221097934. doi: 10.1177/17588359221097934. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35602405 Free PMC article.
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14).
Lee CK, Chon HJ, Cheon J, Lee MA, Im HS, Jang JS, Kim MH, Park S, Kang B, Hong M, Kim JW, Park HS, Kang MJ, Park YN, Choi HJ. Lee CK, et al. Among authors: lee ma. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):56-65. doi: 10.1016/S2468-1253(22)00335-1. Epub 2022 Oct 31. Lancet Gastroenterol Hepatol. 2023. PMID: 36328033 Clinical Trial.
Immunogenicity and Safety of Vaccines against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study.
Baek YJ, Lee YJ, Park SR, Kim KH, Beom SH, Lee CK, Shin SJ, Rha SY, Kim S, Lee KH, Kim JH, Jeong SJ, Ku NS, Choi JY, Yeom JS, Jung M, Ahn JY. Baek YJ, et al. Among authors: lee ck, lee kh, lee yj. Cancer Res Treat. 2023 Jul;55(3):746-757. doi: 10.4143/crt.2022.1541. Epub 2023 Feb 9. Cancer Res Treat. 2023. PMID: 36758955 Free PMC article.
3,184 results